StratifAI

📍 Berlin, Germany🗓 Founded 2023👥 18 employees💰 Last funded May 2025
Hospitals and Health Care🌐 stratifai.com
Website LinkedIn
StratifAI is a precision oncology company developing the next generation of biomarkers to advance cancer diagnostics. Our discovery platform, Polaris™, applies multimodal AI to clinical data, identifying prognostic and predictive biomarkers that enable more equitable and individualized treatment strategies across solid-tumor cancers. Polaris™ Breast, the company’s first diagnostic, assesses metastatic risk in early breast cancer directly from digitized histology slides, supporting better treatment decisions. Retrospectively validated on thousands of patients from Phase III trials and real-world clinical settings, Polaris™ Breast is available for research use only and is undergoing regulatory approval in the EU and US.
3
Total investors
3
Early stage
0
Mid stage
0
Late stage
2023
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Germany
3
Investor activity2024–2025 · investors recorded per year
2024220251
Recent (last 2y)Earlier
Frequently asked questions
Who invested in StratifAI?
StratifAI has 3 investors on record on gritt.io, including 3 early-stage backers.
When did StratifAI last raise funding?
The most recent investment in StratifAI recorded on gritt.io was in May 2025.
When was StratifAI founded?
StratifAI was founded in 2023.
What industry is StratifAI in?
StratifAI operates in Hospitals and Health Care. Find similar Hospitals and Health Care investors on gritt.io.
Where is StratifAI based?
StratifAI is headquartered in Berlin, Germany.